Infliximab Trough Levels Are Not Predictive of Relapse in Patients with IBD in Endoscopic Remission: A Multicenter Cohort Study.

Nienke Z BorrenEmma PaulidesJody L FrinackRyan N OlsonMaria Alice V WillrichC Janneke van der WoudeAshwin N Ananthakrishnan

Published in: Digestive diseases and sciences (2020)

This retrospective multicenter study provides evidence that IFX trough levels during quiescent disease do not predict relapse over 2 years, suggestive that proactive TDM in this setting is not warranted.

Keyphrases

ulcerative colitis
cross sectional
free survival
ultrasound guided
clinical trial
disease activity
double blind
neural stem cells
endoscopic submucosal dissection